ROX-888: Phase II data

In a double-blind, Phase III trial in 127 patients with post-operative pain, the 30 mg dose of ROX-888 met the

Read the full 205 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE